Tokyo Tape
Sign in
← Ain Holdings

Quarterly report · Q2

9627.TEDINET S100PT4M
Period2022-05-01 → 2022-10-31
Filed2022-12-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥171.2bn2022-05-01 → 2022-10-31Cons.Net sales
Revenue¥316.2bn2021-05-01 → 2022-04-30Cons.Net sales (5-year summary)
Revenue¥153.0bn2021-05-01 → 2021-10-31Cons.Net sales
Operating income¥6.8bn2022-05-01 → 2022-10-31Cons.Operating income
Operating income¥5.8bn2021-05-01 → 2021-10-31Cons.Operating income
Ordinary income¥7.3bn2022-05-01 → 2022-10-31Cons.Ordinary income
Ordinary income¥16.0bn2021-05-01 → 2022-04-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥6.1bn2021-05-01 → 2021-10-31Cons.Ordinary income
Profit before tax¥7.2bn2022-05-01 → 2022-10-31Cons.Income before income taxes
Profit before tax¥6.1bn2021-05-01 → 2021-10-31Cons.Income before income taxes
Net income (owners)¥3.8bn2022-05-01 → 2022-10-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥7.1bn2021-05-01 → 2022-04-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.3bn2021-05-01 → 2021-10-31Cons.Profit loss attributable to owners of parent
Net income¥3.8bn2022-05-01 → 2022-10-31Cons.Profit loss
Net income¥3.3bn2021-05-01 → 2021-10-31Cons.Profit loss
Total assets¥231.1bnat 2022-10-31Cons.Assets
Total assets¥212.5bnat 2022-04-30Cons.Assets
Total assets¥210.4bnat 2021-10-31Cons.Total assets (5-year summary)
Total liabilities¥110.3bnat 2022-10-31Cons.Liabilities
Total liabilities¥93.5bnat 2022-04-30Cons.Liabilities
Net assets / equity¥120.9bnat 2022-10-31Cons.Net assets
Net assets / equity¥119.0bnat 2022-04-30Cons.Net assets
Net assets / equity¥115.8bnat 2021-10-31Cons.Net assets (5-year summary)
Cash and deposits¥46.7bnat 2022-10-31Cons.Cash and deposits
Cash and deposits¥59.7bnat 2022-04-30Cons.Cash and deposits
Cash & equivalents¥43.5bnat 2022-10-31Cons.Cash and cash equivalents
Cash & equivalents¥59.5bnat 2022-04-30Cons.Cash and cash equivalents
Cash & equivalents¥58.4bnat 2021-10-31Cons.Cash and cash equivalents
Cash & equivalents¥55.0bnat 2021-04-30dCons.Cash and cash equivalents
Operating cash flow¥8.5bn2022-05-01 → 2022-10-31Cons.Net cash provided by used in operating activities
Operating cash flow¥26.2bn2021-05-01 → 2022-04-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥17.3bn2021-05-01 → 2021-10-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥18.6bn2022-05-01 → 2022-10-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥13.9bn2021-05-01 → 2022-04-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥8.3bn2021-05-01 → 2021-10-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥5.8bn2022-05-01 → 2022-10-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥7.8bn2021-05-01 → 2022-04-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥5.6bn2021-05-01 → 2021-10-31Cons.Net cash provided by used in financing activities
EPS (basic)¥108.32022-05-01 → 2022-10-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥59.772022-08-01 → 2022-10-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥201.472021-05-01 → 2022-04-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥94.682021-05-01 → 2021-10-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥57.62021-08-01 → 2021-10-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio52.3%at 2022-10-31Cons.Equity to asset ratio (5-year summary)
Equity ratio56.0%at 2022-04-30Cons.Equity to asset ratio (5-year summary)
Equity ratio55.0%at 2021-10-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 34
SegmentItemPeriodValue
Otherother segmentsrevenue2022-05-01 → 2022-10-31¥5.8bn
Otherother segmentsrevenue external2022-05-01 → 2022-10-31¥5.8bn
Otherother segmentsrevenue intersegment2022-05-01 → 2022-10-31¥31m
Otherother segmentssegment ordinary income2022-05-01 → 2022-10-31−¥18m
Reconciling Itemsreconcilingrevenue2022-05-01 → 2022-10-31−¥31m
Reconciling Itemsreconcilingrevenue intersegment2022-05-01 → 2022-10-31−¥31m
Reconciling Itemsreconcilingsegment ordinary income2022-05-01 → 2022-10-31−¥3.8bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue2022-05-01 → 2022-10-31¥153.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2022-05-01 → 2022-10-31¥153.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2022-05-01 → 2022-10-31¥10.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2022-05-01 → 2022-10-31¥12.2bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2022-05-01 → 2022-10-31¥12.2bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2022-05-01 → 2022-10-31¥349m
—segment totalrevenue2022-05-01 → 2022-10-31¥171.2bn
—segment totalrevenue external2022-05-01 → 2022-10-31¥171.2bn
—segment totalrevenue intersegment2022-05-01 → 2022-10-31¥31m
—segment totalsegment ordinary income2022-05-01 → 2022-10-31¥11.1bn
Otherother segmentsrevenue2021-05-01 → 2021-10-31¥6.3bn
Otherother segmentsrevenue external2021-05-01 → 2021-10-31¥6.3bn
Otherother segmentsrevenue intersegment2021-05-01 → 2021-10-31¥47m
Otherother segmentssegment ordinary income2021-05-01 → 2021-10-31−¥121m
Reconciling Itemsreconcilingrevenue2021-05-01 → 2021-10-31−¥47m
Reconciling Itemsreconcilingrevenue intersegment2021-05-01 → 2021-10-31−¥47m
Reconciling Itemsreconcilingsegment ordinary income2021-05-01 → 2021-10-31−¥3.1bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue2021-05-01 → 2021-10-31¥136.9bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2021-05-01 → 2021-10-31¥136.9bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2021-05-01 → 2021-10-31¥10.5bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2021-05-01 → 2021-10-31¥9.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2021-05-01 → 2021-10-31¥9.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2021-05-01 → 2021-10-31−¥1.1bn
—segment totalrevenue2021-05-01 → 2021-10-31¥153.0bn
—segment totalrevenue external2021-05-01 → 2021-10-31¥153.0bn
—segment totalrevenue intersegment2021-05-01 → 2021-10-31¥47m
—segment totalsegment ordinary income2021-05-01 → 2021-10-31¥9.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 565
ItemContextValueUnit
Other clPrior1YearInstant5321000000JPY
Other clCurrentQuarterInstant4284000000JPY
Current liabilitiesPrior1YearInstant81805000000JPY
Current liabilitiesCurrentQuarterInstant93308000000JPY
Long term loans payablePrior1YearInstant5815000000JPY
Long term loans payableCurrentQuarterInstant10038000000JPY
Net defined benefit liabilityPrior1YearInstant3578000000JPY
Net defined benefit liabilityCurrentQuarterInstant4360000000JPY
Other nclPrior1YearInstant2252000000JPY
Other nclCurrentQuarterInstant2564000000JPY
Noncurrent liabilitiesPrior1YearInstant11645000000JPY
Noncurrent liabilitiesCurrentQuarterInstant16964000000JPY
LiabilitiesPrior1YearInstant93450000000JPY
LiabilitiesCurrentQuarterInstant110272000000JPY
Capital stockPrior1YearInstant21894000000JPY
Capital stockCurrentQuarterInstant21894000000JPY
Capital surplusPrior1YearInstant20500000000JPY
Capital surplusCurrentQuarterInstant20504000000JPY
Retained earningsPrior1YearInstant78661000000JPY
Retained earningsCurrentQuarterInstant80533000000JPY
Treasury stockPrior1YearInstant-2018000000JPY
Treasury stockCurrentQuarterInstant-2000000000JPY
Shareholders equityPrior1YearInstant119038000000JPY
Shareholders equityCurrentQuarterInstant120932000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant-39000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant-78000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-75000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-63000000JPY
Valuation and translation adjustmentsPrior1YearInstant-114000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant-141000000JPY
Non controlling interestsPrior1YearInstant86000000JPY
Non controlling interestsCurrentQuarterInstant78000000JPY
Net assetsPrior1YearInstant119010000000JPY
Net assetsCurrentQuarterInstant120869000000JPY
Liabilities and net assetsPrior1YearInstant212461000000JPY
Liabilities and net assetsCurrentQuarterInstant231141000000JPY
Net salesPrior1YTDDuration152972000000JPY
Net salesCurrentYTDDuration171204000000JPY
Cost of salesPrior1YTDDuration130133000000JPY
Cost of salesCurrentYTDDuration146217000000JPY
Gross profitPrior1YTDDuration22838000000JPY
Gross profitCurrentYTDDuration24986000000JPY
Selling general and administrative expensesPrior1YTDDuration17062000000JPY
Selling general and administrative expensesCurrentYTDDuration18202000000JPY
Operating incomePrior1YTDDuration5776000000JPY
Operating incomeCurrentYTDDuration6784000000JPY
Interest income noiPrior1YTDDuration21000000JPY
Interest income noiCurrentYTDDuration23000000JPY
Dividends income noiPrior1YTDDuration21000000JPY
Dividends income noiCurrentYTDDuration31000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-04-30pass rounding
balance sheet identityconsolidated 2022-10-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-04-30pass
statement vs summary · net assetsconsolidated 2022-10-31pass
statement vs summary · net income attributable to parentconsolidated 2021-05-01/2021-10-31pass
statement vs summary · net income attributable to parentconsolidated 2022-05-01/2022-10-31pass
statement vs summary · operating cash flowconsolidated 2021-05-01/2021-10-31pass
statement vs summary · operating cash flowconsolidated 2022-05-01/2022-10-31pass
statement vs summary · revenueconsolidated 2021-05-01/2021-10-31pass
statement vs summary · revenueconsolidated 2022-05-01/2022-10-31pass
statement vs summary · total assetsconsolidated 2022-04-30pass
statement vs summary · total assetsconsolidated 2022-10-31pass